CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-01 | Walker Neal President and CEO | Option exercise · Restricted stock units | −18,275 | 54,825 | ||
| 2022-02-09 | Monahan Joseph Chief Scientific Officer | Sale | −383 | $12.68 | $5K | 87,301 |
| 2022-02-09 | Ruffo Frank Chief Financial Officer | Sale | −1,388 | $12.66 | $18K | 172,359 |
| 2022-02-09 | Walker Neal President and CEO | Sale | −3,595 | $12.66 | $46K | 1,239,387 |
| 2022-02-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +1,050 | 87,684 | ||
| 2022-02-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,050 | 0 | ||
| 2022-02-01 | Ruffo Frank Chief Financial Officer | Option exercise | +3,875 | 173,747 | ||
| 2022-02-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −3,875 | 0 | ||
| 2022-02-01 | Walker Neal President and CEO | Option exercise | +10,800 | 1,242,982 | ||
| 2022-02-01 | Walker Neal President and CEO | Option exercise · Restricted Stock Units | −10,800 | 0 | ||
| 2022-02-01 | Loerop James Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2022-02-01 | Loerop James Chief Business Officer | Grant or award · Restricted Stock Units | +45,000 | 45,000 | ||
| 2022-01-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +3,875 | 118,571 | ||
| 2022-01-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +27,905 | 146,476 | ||
| 2022-01-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +6,638 | 153,114 | ||
| 2022-01-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +7,100 | 160,214 | ||
| 2022-01-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Units | −3,875 | 0 | ||
| 2022-01-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Units | −27,905 | 0 | ||
| 2022-01-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Unit | −6,638 | 0 | ||
| 2022-01-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Units | −7,100 | 0 |
Page 27 of 34 · 680 trades